Nissui Of Japan To Market Fast Test For Seafood Allergen
This article was originally published in PharmAsia News
Executive Summary
Japan's Nissui Pharmaceutical says it has worked with a major seafood giant to develop a quick test for determining whether people have an allergic reaction to shrimp or crabs. Japanese law requires labels on those seafoods to state whether they contain the protein tropomyosin. Nissui, which makes reagents, is affiliated with Nippon Suisan Kaisha, a seafood dealer. Nissui plans to begin marketing the kit to food manufacturers that run different foods on the same production line to check for accidental contamination. (Click here for more - a subscription may be required
You may also be interested in...
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.